Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation
Top Cited Papers
Open Access
- 10 January 2020
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 11 (1) , 1-17
Abstract
Psoriasis is an autoimmune skin disease, where chronic immune responses due to exaggerated cytokine signaling, abnormal differentiation, and evasion of keratinocytes apoptosis plays a crucial role in mediating abnormal keratinocytes hyperproliferation. From the therapeutic perspective, the molecules with strong anti-proliferative and anti-inflammatory properties could have tremendous relevance. In this study, we demonstrated that piperlongumine (PPL) treatment effectively abrogated the hyperproliferation and differentiation of keratinocytes by inducing ROS-mediated late apoptosis with loss of mitochondrial membrane potential. Besides, the arrest of cell cycle was found at Sub-G1 phase as a result of DNA fragmentation. Molecularly, inhibition of STAT3 and Akt signaling was observed with a decrease in proliferative markers such as PCNA, ki67, and Cyclin D1 along with anti-apoptotic Bcl-2 protein expression. Keratin 17 is a critical regulator of keratinocyte differentiation, and it was found to be downregulated with PPL significantly. Furthermore, prominent anti-inflammatory effects were observed by inhibition of lipopolysaccharide (LPS)/Imiquimod (IMQ)-induced p65 NF-κB signaling cascade and strongly inhibited the production of cytokine storm involved in psoriasis-like skin inflammation, thus led to the restoration of normal epidermal architecture with reduction of epidermal hyperplasia and splenomegaly. In addition, PPL epigenetically inhibited histone-modifying enzymes, which include histone deacetylases (HDACs) of class I (HDAC1–4) and class II (HDAC6) evaluated by immunoblotting and HDAC enzyme assay kit. In addition, our results show that PPL effectively inhibits the nuclear translocation of p65 and a histone modulator HDAC3, thus sequestered in the cytoplasm of macrophages. Furthermore, PPL effectively enhanced the protein–protein interactions of HDAC3 and p65 with IκBα, which was disrupted by LPS stimulation and were evaluated by Co-IP and molecular modeling. Collectively, our findings indicate that piperlongumine may serve as an anti-proliferative and anti-inflammatory agent and could serve as a potential therapeutic option in treating psoriasis.Keywords
This publication has 69 references indexed in Scilit:
- The Role of p38 MAPK in the Aetiopathogenesis of Psoriasis and Psoriatic ArthritisJournal of Immunology Research, 2013
- Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in gliomaOncogene, 2012
- Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophagesProceedings of the National Academy of Sciences, 2012
- Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasisCell Death & Disease, 2012
- Consequences of Fuzziness in the NFκB/IκBα Interaction2012
- Improved Elution Conditions for Native Co-ImmunoprecipitationPLOS ONE, 2011
- Histone Deacetylase-3 Activation Promotes Tumor Necrosis Factor-α (TNF-α) Expression in Cardiomyocytes during Lipopolysaccharide StimulationJournal of Biological Chemistry, 2010
- HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimenProceedings of the National Academy of Sciences, 2008
- Misbehaving macrophages in the pathogenesis of psoriasisJournal of Clinical Investigation, 2006
- Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammationJournal of Clinical Investigation, 2006